title: Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy.
authors.forename: E
authors.initials: E
authors.lastname: Gyan
authors.forename: S
authors.initials: S
authors.lastname: Darre
authors.forename: B
authors.initials: B
authors.lastname: Jude
authors.forename: N
authors.initials: N
authors.lastname: Cambier
authors.forename: J L
authors.initials: JL
authors.lastname: Demory
authors.forename: F
authors.initials: F
authors.lastname: Bauters
authors.forename: C
authors.initials: C
authors.lastname: Rose
mesh_terms: D020016:Activated Protein C Resistance / Q000150:complications* / Q000235:genetics; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002448:Cell Adhesion; D004910:Erythrocyte Membrane / Q000473:pathology; D005039:Etilefrine / Q000627:therapeutic use; D005165:Factor V / Q000032:analysis*; D006455:Hemoglobins, Abnormal / Q000032:analysis*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D011317:Priapism / Q000188:drug therapy / Q000209:etiology*; D011655:Pulmonary Embolism / Q000209:etiology; D012008:Recurrence; D013156:Splenectomy / Q000009:adverse effects*; D013922:Thrombocytosis / Q000150:complications; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006455:Hemoglobins, Abnormal; D014662:Vasoconstrictor Agents; C095381:factor V Leiden; C092638:hemoglobin Perth-Abraham Lincoln; D005165:Factor V; D006918:Hydroxyurea; D005039:Etilefrine